AEGIRBIO

aegirbio-logo

Aegirbio is a Swedish diagnostics company offering tests to monitor and optimize the dosing of biological drugs by means of a unique, patented technology platform.

#People #Financial #Event #Website #More

AEGIRBIO

Industry:
Biotechnology

Founded:
2019-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.aegirbio.com

Total Employee:
1+

Status:
Active

Contact:
+1 858 203 1169

Total Funding:
1.91 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Nginx Google Cloud YouTube COVID-19 Ubuntu Google Cloud CDN



Current Advisors List

sofia-bertling_image

Sofia Bertling Board Member @ Aegirbio
Board_member
2022-06-01

Current Employees Featured

vasiliki-fragkou_image

Vasiliki Fragkou
Vasiliki Fragkou Chief Operating Officer @ Aegirbio
Chief Operating Officer
2023-01-01

Acquisitions List

Date Company Article Price
2020-09-08 Viraspec Viraspec acquired by Aegirbio N/A

Investors List

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Aegirbio

Official Site Inspections

http://www.aegirbio.com Semrush global rank: 11.43 M Semrush visits lastest month: 162

  • Host name: 38.228.117.34.bc.googleusercontent.com
  • IP address: 34.117.228.38
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Aegirbio"

AegirBio AB changes name to Magnasense AB

Mar 5, 2025 Today, AegirBio AB announces that the companyโ€™s name has officially been changed to Magnasense AB in the Swedish Companies Register. This registration follows that โ€ฆSee details»

Uppdatering om organisation i AegirBio - Magnasense

AegirBio är ett svenskt diagnostikföretag som bildades för att via sin unika patenterade teknologiplattform erbjuda tester för att övervaka och optimera doseringen av biologiska โ€ฆSee details»

The next step is taken for Aegirbio, a pre-IPO based on a value of โ€ฆ

Feb 19, 2025 Aegirbio's test for the follow-up of treatment with Tysabri, a drug used to treat patients with Multiple Sclerosis MS, will now be set up in the United States. The company's โ€ฆSee details»

Magnasense - Crunchbase Company Profile & Funding

Magnasense is basing its operations on laboratory-developed tests and technologies for patient follow-up during biological drug treatment; quantitative near-patient tests for routine control in โ€ฆSee details»

AegirBio Company Profile - Office Locations, Competitors ... - Craft

AegirBio kr92 k in annual revenue in FY 2023. See insights on AegirBio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

AegirBio AB changes name to Magnasense AB | Placera

Jul 8, 2024 Consequently, the board of AegirBio proposed, pursuant to the authority granted by the annual general meeting 2024, Magnasense AB as the new company name which was โ€ฆSee details»

AegirBio AB (publ): Shareholders Board Members Managers and โ€ฆ

Apr 30, 2020 Magnasense AB, formerly AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and โ€ฆSee details»

AegirBio announces strategic name change to MagnOral AB

Mar 3, 2025 Lund, 4 May 2024 โ€“ AegirBio AB, a pioneer in magnetic test strip technology and saliva diagnostics, announces that it will change its name to MagnOral AB, pending approval โ€ฆSee details»

Magnasense 2025 Company Profile: Stock Performance

Description AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The โ€ฆSee details»

AegirBio_Q4 Draft (240328 v8) ENG - files.wewoosh.com

AegirBio AB has received a phase 1 award from the National Institutes of Health (NIH) for an accessibility project (RADx). The award grants AegirBio MUSD 1.2 from NIH, of which โ€ฆSee details»

AegirBio AB (AEGIR) | Investor Relations Data & Reports

Browse AegirBio AB's (AEGIR) investor relations materials including 2024 annual reports, financial statements, ESG data, and company filings.See details»

Annual Report 2021 - filel.mywoosh.app

Aegirbio is a biotechnology company founded with the business concept of developing and commercializing tests to monitor the dosing of biological drugs to ensure that the right dosing โ€ฆSee details»

AegirBio AB (publ): Shareholders Board Members Managers and โ€ฆ

AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers โ€ฆSee details»

Aegirbio creates the multi-diagnostic company of the future โ€“ โ€ฆ

Jan 28, 2021 The Board of Directors of AegirBio AB (publ) has today resolved to acquire LifeAssays AB and Abreos Bioscience. Through these acquisitions, Aegirbio becomes a โ€ฆSee details»

HEALTH CHECK. PRECISION. SIMPLICITY.

AegirBio, established in 2019, is a Swedish diagnostics company that develops and commercializes diagnostic tests, with a key focus on monitoring and optimizing the dosing of โ€ฆSee details»

AegirBio_Q3-Draft-231027 ENG - Wewoosh

AegirBio AB has received a phase 1 award from the National Institutes of Health (NIH) for an accessibility project (RADx). The award grants AegirBio MUSD 1.2 from NIH, of which โ€ฆSee details»

Aegirbio - Overview, News & Competitors | ZoomInfo.com

Aegirbio is a Swedish diagnostics company offering tests to monitor and optimize the dosing of biological drugs by means of a unique, patented technology platform.See details»

Company Updates - Magnasense

May 2, 2024 Brand Change Announcement: AegirBio AB has officially changed its name to Magnasense AB. The new website, www.magnasense.com, launched on 9 July 2024, with โ€ฆSee details»

The next step is taken for Aegirbio AB, LifeAssays and Abreos ...

Jan 17, 2020 Aegirbio's test for the follow-up of treatment with Tysabri, a drug used to treat patients with Multiple Sclerosis MS, will now be set up in the United States. The company's โ€ฆSee details»

AegirBio UK facility ISO 13485 compliant - Magnasense

Mar 3, 2025 Aegirbio is a Swedish diagnostics company offering tests to monitor and optimize the dosing of biological drugs by means of a unique, patented technology platform.See details»

linkstock.net © 2022. All rights reserved